Nanoparticle-driven drug delivery system for cardiovascular treatment

Area of Science:

• Cardiology
• Nanomedicine
• Biomedical Engineering

Background:

• Cardiovascular disease (CVD) is a leading global health concern, affecting millions and causing significant mortality.
• Current treatments face challenges, necessitating innovative therapeutic strategies.
• Nanomaterials offer unique properties for advanced medical applications.

Purpose of the Study:

• To review the clinical opportunities and therapeutic potential of nanomedicine in treating cardiovascular diseases.
• To focus on nanoparticle-based drug delivery systems for cardiac conditions.

Main Methods:

• Review of recent advances in nanoparticle-based therapeutics for CVD.
• Concentration on metal, lipid, and polymer nanoparticles for drug delivery.
• Emphasis on targeted delivery to cardiac tissues.

Main Results:

• Nanoparticles demonstrate increased target specificity and sensitivity for cardiac tissues.
• Heart-targeted nanocarriers show promise for treating hypertension, atherosclerosis, and myocardial infarction.
• Nanomedicine offers a safe and efficient drug delivery method for CVD.

Conclusions:

• Nanoparticle-based therapeutics represent a significant advancement in cardiovascular nanomedicine.
• Drug delivery via nanoparticles holds substantial therapeutic potential for clinical applications in CVD.
• Emerging nanomedicine approaches are crucial for addressing the challenges in CVD treatment.